Dow Up0.76% Nasdaq Up0.69%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
34.25 Down 0.78(2.23%) Oct 24, 4:00PM EDT
|After Hours : 34.25 0.00 (0.00%) Oct 24, 4:52PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 97,130   80,518   92,592   84,920  
Cost of Revenue19,057  15,688  18,536  17,372  
Gross Profit 78,073   64,830   74,056   67,548  
Operating Expenses
Research Development16,448  14,522  14,302  13,839  
Selling General and Administrative50,645  46,892  47,007  42,336  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 10,980   3,416   12,747   11,373  
Income from Continuing Operations
Total Other Income/Expenses Net165  172  167  162  
Earnings Before Interest And Taxes11,145  3,588  12,914  11,535  
Interest Expense426  92  286  544  
Income Before Tax10,719  3,496  12,628  10,991  
Income Tax Expense6,032  2,793  6,437  3,513  
Minority Interest -   -   -   -  
Net Income From Continuing Ops4,687  703  6,191  7,478  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 4,687   703   6,191   7,478  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 4,687   703   6,191   7,478  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.